North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Product Description
In-house Standards
AI Product Description
*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>Sofosbuvir (CAS <strong>1190307-88-0</strong>) is a nucleotide analog prodrug designed for the treatment of Hepatitis C virus. Its core synthesis involves complex phosphoramidite chemistry to ensure high purity and stability. The molecular formula is <strong>C22H29FN6O9P</strong>.</p>
<h3>Application</h3>
<ul>
<li><strong>Pharmaceutical Manufacturing:</strong> Key active ingredient in direct-acting antiviral regimens.</li>
<li><strong>Hepatology:</strong> Used in combination therapies for chronic HCV infection genotypes 1-4.</li>
<li><strong>Research & Development:</strong> Standard reference material for virology studies.</li>
</ul>
<h3>Precautions</h3>
<p>Strictly contraindicated with amiodarone due to severe bradycardia risks. Store under inert atmosphere at 2-8°C protected from light. Handle with PPE as it is a potent pharmaceutical intermediate.</p>